Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,979,952 |
|
|||||
| News | - | ||||||
| Day High | 27.96 | Low High |
|||||
| Day Low | 27.30 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BridgeBio Pharma Inc | BBIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.12 | -0.43% | 27.82 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 28.30 | 27.30 | 27.96 | 27.82 | 27.94 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 17,934 | 1,979,952 | $ 27.69 | $ 54,826,009 | - | 13.26 - 44.32 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:54:52 | 1 | $ 27.70 | USD |
BridgeBio Pharma (BBIO) Options Flow Summary
BridgeBio Pharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 4.89B | 175.83M | - | 9.3M | -643.2M | -3.66 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BridgeBio Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BBIO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 29.27 | 29.88 | 27.30 | 28.63 | 1,538,421 | -1.45 | -4.95% |
| 1 Month | 25.22 | 31.155 | 24.95 | 28.65 | 1,505,322 | 2.60 | 10.31% |
| 3 Months | 31.605 | 31.80 | 23.68 | 28.08 | 1,650,346 | -3.79 | -11.98% |
| 6 Months | 29.63 | 44.32 | 23.68 | 32.77 | 1,743,688 | -1.81 | -6.11% |
| 1 Year | 13.93 | 44.32 | 13.26 | 29.58 | 2,026,928 | 13.89 | 99.71% |
| 3 Years | 58.16 | 65.33 | 4.98 | 20.62 | 2,073,216 | -30.34 | -52.17% |
| 5 Years | 30.61 | 73.50 | 4.98 | 24.22 | 1,505,728 | -2.79 | -9.11% |
BridgeBio Pharma Description
| BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy. The company focus on genetic diseases because they exist at the intersection of high unmet patient need and tractable biology. |
